NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,597 | -0.4% | 1,500 | 0.0% | 0.00% | – |
| Q2 2023 | $152,254 | -16.8% | 1,500 | -24.4% | 0.00% | – |
| Q1 2023 | $182,959 | +34.7% | 1,984 | +32.3% | 0.00% | – |
| Q4 2022 | $135,834 | -15.1% | 1,500 | -29.0% | 0.00% | – |
| Q3 2022 | $160,000 | +26.0% | 2,114 | +40.9% | 0.00% | – |
| Q2 2022 | $127,000 | -3.8% | 1,500 | 0.0% | 0.00% | – |
| Q1 2022 | $132,000 | +7.3% | 1,500 | 0.0% | 0.00% | – |
| Q3 2021 | $123,000 | -9.6% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $136,000 | +6.2% | 1,500 | 0.0% | 0.00% | – |
| Q1 2021 | $128,000 | -9.2% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $141,000 | +7.6% | 1,500 | 0.0% | 0.00% | – |
| Q3 2020 | $131,000 | -0.8% | 1,500 | 0.0% | 0.00% | – |
| Q2 2020 | $132,000 | +6.5% | 1,500 | 0.0% | 0.00% | – |
| Q1 2020 | $124,000 | -12.7% | 1,500 | 0.0% | 0.00% | – |
| Q4 2019 | $142,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |